Tokyo, Sept. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059071) titled 'Rapid Detection of Mild Cognitive Impairment (MCI) through Writing Analysis' on Sept. 13.
Study Type:
Observational
Primary Sponsor:
Institute - Kawasaki University of Medical Welfare
Condition:
Condition - Mild Cognitive Impairment (MCI)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The primary objective of this study is to develop a structured model for the rapid detection of mild cognitive impairment (MCI) by analyzing short written sentences from the MMSE-J sentence-writing item and identifying characteristic writing patterns.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 60
years-old
=
Gender - Male and Female
Key inclusion criteria - Age 60 years or older
No history of neurological disorders
Able to complete cognitive assessments (MMSE-J, CDR, writing tasks)
Key exclusion criteria - History of dementia diagnosis
Presence of aphasia
Inability to complete cognitive assessments
Target Size - 150
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 28 Day
Date of IRB - 2025 Year 08 Month 28 Day
Anticipated trial start date - 2025 Year 09 Month 01 Day
Last follow-up date - 2031 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067554
Disclaimer: Curated by HT Syndication.
